Background: Metabolic abnormalities associated with type 2 diabetes mellitus (DM2) are caused in part by inadequate insulin action and resulting changes in gene expression in the skeletal muscle. Two recent, independent studies of human skeletal muscle biopsies from ethnically diverse DM2 patients have identified coordinated reductions in the expression of the oxidative phosphorylation (OXPHOS) genes. Whether these reductions are a consequence or a cause of impaired insulin sensitivity remains an open question.
INTRODUCTION
T YPE 2 DIABETES MELLITUS (DM2), a complex multigenic disease, requires system-level measurements and modeling to improve our mechanistic understanding of its pathophysiology and corresponding therapeutic intervention. While the human genome sequence and genome-wide profiling technologies have facilitated system-level measurements, methods to interpret and integrate these measurements into models of discrete signaling, metabolic, and gene regulatory mechanisms have lagged behind. 1 In this paper, we describe a novel approach to define discrete mechanisms of gene regulation in skeletal muscle biopsies from DM2 patients. We integrate genome-wide profiling measurements with system-level models of molecular cause-and-effect relationships and use computer-aided causal reasoning to discover mechanisms that can be causally linked to altered expression profiles in DM2. The emerging hypotheses describe biologic effects in DM2 and offer important cues for molecular targeted therapy.
BACKGROUND
Metabolic abnormalities associated with DM2 are in part caused by changes in transcriptional regulatory networks of skeletal muscle. Two recent, independent transcript profile studies of human skeletal muscle biopsies from DM2 patients have shown the coordinated down-regulation in genes associated with oxidative phosphorylation and ATP biosynthesis and those expressed in the mitochondria (collectively called OXPHOS). 2, 3 These studies explained altered OXPHOS transcription by regulation of the transcriptional activity of NRF1 and PPARGC1a (gene names are given in the Appendix); however, discrete mechanisms that link OXPHOS transcription to both its downstream effects and its upstream causes need to be defined in order to determine if altered OXPHOS transcription is a cause or an effect of the characteristics of DM2 such as impaired insulin signaling. In this paper, we have developed a computational approach using a model of human skeletal muscle and computer-aided causal reasoning to interpret expression profiles to define discrete mechanisms of regulation in DM2.
A number of statistical and network reconstruction methods have been applied to interpret expression profiles. Statistical methods can identify associations between genes according to their expression profiles (e.g., clustering, 4, 5 principal component analysis, 6 or relevance networks 7 ), but frequently the associations are abstract, and even promoter analysis cannot define a discrete mechanism of regulation. Additionally, numerous network reconstruction methods from systems identification and engineering have been used to infer potential transcriptional networks solely from expression profiles (Boolean networks, 8 linear models, 9 differential equation models, 10 and Bayesian networks 11 ).
While these network reconstruction methods in principle are capable of defining discrete mechanisms of regulation, as typically applied they require large numbers of expression profiles to define even small networks (e.g., 25 gene regulatory networks require Ͼ100 expression profiles for typical Bayesian methods 12 ), and even under these ideal conditions, the direction and sign of the influence of regulatory relationships can be very difficult to determine solely from the expression profiles. Irrespective of the reconstruction methods employed, numerous regulatory models can be generated that are consistent with the changes in expression, and prior biological knowledge in the form of cause-and-effect relationships is crucial to evaluating and ranking potential models. [13] [14] [15] The use of prior knowledge has received considerable attention, but its implementation on a large scale has been hampered because of the difficulty in assembling large amounts of knowledge into a unified and computationally tractable form. 1, 12 We have overcome this challenge, and in the Causal modeling in biology section we describe our approach to assembling knowledge in the form of a large-scale, causal model of human skeletal muscle. In the RNA expression state changes analysis and Reverse and forward causal analysis sections we describe how we engraft profiling data into this model and use computer-aided causal analysis to define discrete mechanisms of regulation for signal, metabolic, and gene expression networks. In the Results section we apply both our causal model and analysis techniques to interpret the expression profiles from the Scandinavian 2 and Mexican-American 3 studies. In the Conclusions section we discuss our mechanistic findings relative to altered OXPHOS transcription and other characteristics of DM2.
METHODS

Causal modeling in biology
Qualitative causal models. A model that describes the influence exerted by one component in a system (e.g., protein abundance or activity) on another component is called a causal model. Causal models provide a statistical framework to infer (1) causes for changes in the system's components as it transitions between states (e.g., what are the potential causes for changes in muscle gene expression profiles in DM2?) and (2) effects on the components resulting from system perturbations (e.g., what muscle gene expression changes are attributable only to increased insulin levels?). Causal models are also computationally attractive because this inferencing can be automated since the model can be rendered as a directed graph. In Figure 1 the transcriptional activity of PPARG and NRF1 as well as the transcriptional activity of the transcriptional co-activator PPARGC1a are represented as nodes. The edges and their directionality assert that the transcriptional activity of PPARGC1a positively influences the transcriptional activity of PPARG and NRF1. Additionally, the influence of indirectly connected nodes can be identified by tracing connecting paths and multiplying the signs of the intervening edges as in the case of the AGTR1.
This kind of causal model is qualitative in nature in that it describes only the vector of influence that PPARGC1a's transcriptional activity exerts on PPARG's and NRF1's transcriptional activity. The qualitative causal model does not describe the magnitude of the influence or how multiple influences should be integrated. Qualitative causal models occupy a tractable middle ground in a taxonomy of models between (1) more abstract association models that cannot be used to infer causes or effects but require no prior knowledge and (2) more detailed quantitative models that can be used to infer causes and effects but require very detailed knowledge such as diffusion or rate constants in a specific subcellular environments (for recent reviews, see Rice and Stolovitzky 16 and Ideker et al. 1 ).
Creating and populating a causal model describing human skeletal muscle biology. Our modeling and analyses techniques are aimed at facilitating inference on the causes for and effects of the changes in RNA expression levels. Our analysis techniques require leveraging prior knowledge to gain efficiency and resolution over purely statistical approaches; therefore, we employ an ontology to structure and render computable knowledge about the causes for changes in activities and abundance of the components in the muscle and the effects those causes engender. At the highest level our ontology describes the measurable components in molecular biology (protein abundance, catalytic activities, biological processes, etc.) and the relationships between the components (associative or causal, including the sign of the influence). Our ontology also describes the biological context of the components and their relationships by linking them to specific organisms, tissues, cell types, and subcellular compartments.
Using this ontology as a framework, we conducted a large-scale knowledge extraction and unification effort to mine several diverse biological databases such as Locuslink, GO, OMIM, CSNDB, KEGG, and Homologene to create a model of human skeletal muscle biology and DM2. Because the potential causes for changes in the measurable components of the muscle are not recorded in a machine-readable form, we augmented our model through manual and semiautomated methods by extracting causal relationships from more than 12,000 distinct scientific articles whose abstracts were contained in Medline and deemed relevant to skeletal muscle biology. The model contains more than 157,000 molecular components (e.g., genes, protein, metabolites, pathways, etc.) and more than 210,000 relationships between those components (greater than 24,000 of which are causal). For example, the model describes the molecular effects of increased insulin, fatty acids, and glucose on muscle as well as many other causes for changes in gene expression including glucose transport, lipid metabolism, insulin signaling, glucose oxidation, and glucosamine metabolism.
RNA expression state changes analysis
RNA expression profiles of human skeletal muscle biopsies from DM2 patients (five samples) compared with family history-negative control subjects (five samples) from the Mexican-American study 3 and DM2 patients (18 samples) compared with normal glucose tolerance control subjects (17 samples) from the Scandinavian study 2 were separately analyzed using R and the Bioconductor's affy and limma packages. 17, 18 Briefly, raw intensities were normalized within each array with locally weighted linear regression (loess), low-intensity signals were filtered, and global scaling on each array was performed to make the intensities between the DM2 patients and control subjects comparable within each study.
Separate differential expression analyses were done on the normalized data from each study. A gene-by-gene analysis of variance was performed comparing the DM2 patients with control subjects; genes that were differentially expressed (P Ͻ 0.05 after false discovery rate correction) in two or more comparisons between the DM2 and the control subjects were used to classify the samples in the respective studies. Interestingly, only 14 genes were consistently modulated in both studies (Fig. 2 ). Using over-representation analysis the original studies concluded and our re-analysis confirms that OXPHOS genes were present in the modulated set of genes at disproportionately high frequencies. Since our causal model is qualitative in nature, we categorized the expression changes before using them in causal analysis. The expression changes were divided into three categories: genes that were increased, decreased, or unchanged in DM2 muscle compared with control.
Reverse and forward causal analysis
Our causal analysis algorithms take as inputs (1) prior knowledge in the form of a causal model and (2) a set of changes in the components of a system profiled in different states (e.g., changes in the muscle gene expression profiles comparing the DM2 state with the normal state). In the case of RNA expression data, reverse causal analysis interrogates the model to find immediate upstream transcriptional controllers (e.g., the abundance or activity of transcription factors, co-activators, co-repressors, or modulators of transcript stability) whose increase or decrease hypothetically could be a cause of the observed changes in the RNA profiles. Once immediate upstream controllers are located, forward causal analysis then scores each hypothetical cause by comparing the predicted RNA profile with the observed profile. As shown in Figure 3 , reverse causal analysis finds five transcriptional mod- ulators that could account for the observed changes in RNA profiles of ATP50, NDUFA2, UQCRB, and COX7C. Forward causal analysis predicts that only a decrease in the transcriptional activity of PPARGC1a can explain all of the changes with no contradictions.
Each hypothesis is scored according to two probabilistic scoring metrics-"richness" and "concordance"-which examine orthogonal aspects of the probability of a hypothetical cause explaining a given number of state changes. "Richness" is the probability that the number of observed changes in a given model could have occurred by chance alone. "Concordance" is the probability that the number of observed changes that match the directionality (e.g., increased or decreased abundance) of the changes predicted by the model could have occurred by chance alone. Only hypotheses that pass preset metric thresholds are used as inputs for continued upstream exploration in the model in progressive cycles of reverse and forward causal analyses. Collections of hypothetical causes that are highly concordant with the observed expression profiles are the output of causal analysis and form the inferred mechanism of regulation.
RESULTS
Assessing model competence
Before using the model to infer mechanisms of regulation in DM2 muscle, we probed the competency of the model to do reasoning in the muscle. Competency was assessed by introducing a set of perturbations, and then using forward causal analysis to predict effects caused by such perturbations. Numerous perturbations were used to probe the model, and Table 1 details a few examples. The predicted efficacy of the thiazolidinedione class of drugs used clinically as insulin sensitizers is shown in Figure 4 . Through forward causal analysis, the model accurately predicted (1) enhanced insulin sensitivity (via IRS1 tyrosine phosphorylation) and increased glucose import (via increased GLUT4 expression), (2) decreased cytokine-induced insulin resistance (via decreased TNFa abundance and expressed IL-6), and (3) enhanced lipid metabolism (via increased abundance of expressed LPL caused by increased transcriptional activity of PPARG).
The competence of the model to discover the transcriptional network of the OXPHOS genes is shown in Figure 5A . Since much modulation of the OXPHOS genes is predicated on decreases in the transcriptional activity of the coactivator PPARGC1a, forward causal analysis was performed using PPARGC1a as a starting point. The causal analysis confirmed that a decrease in PPARGC1a transcriptional activity and consequently a decrease in NRF1 transcriptional activity could explain the observed changes in expression profiles of OXPHOS genes from both of the studies. Furthermore, the causal analysis outlined numerous plausi- ble mechanisms by which decreased transcriptional activity of PPARGC1a could cause decreases in insulin sensitivity and glucose import in muscle. An example mechanism mediated directly through decreased GLUT4 expression or indirectly through decreased UCP2 expression is shown in Figure 5B . Reverse causal analyses using the expression profiles from the studies allowed us examine all such mechanisms known by the model and rank them by concordance to the observed profiles and linkage to insulin signaling as well as glucose import.
Causal analysis of expression changes in DM2 muscle
The causal model contained transcriptional control information for approximately 56% of genes that were modulated combined across the studies 2,3 (101 of 221 Scandinavian and 30 of 77 Mexican-American modulated genes). Reverse causal analyses was performed on each study separately, and regulatory mechanisms were scored and ranked based on concordance between predicted and observed expression changes. Intersection of the causal analyses across the two studies revealed a regulatory mechanism that is highly significant according to the richness and concordance metrics and can explain 49 of the 131 gene expression changes known to the model (Table 2 and Fig.  6 ). The mechanism details that decreased calcineurin signaling can modulate PPARGC1a protein abundance by decreasing the transcriptional activity of the MEF2 family, 19 which in turn can decrease the transcriptional activity of PPARGC1a and correspondingly explain the decreases in NRF1-regulated genes. A decrease in PPARGC1a protein abundance is further supported by the observed changes in expression of STAT3 and LPL in both studies. has been the targeting of leukocyte-associated calcineurin as a means to suppress leukocyte function 22, 23 and prolong graft survival. The hypothetical mechanism presented here suggests that inhibition of skeletal muscle calcineurin by these agents could impair glucose uptake and insulin signaling at the level of muscle and explains why immunosuppressive therapy with these inhibitors represents a significant independent risk factor for the development of PTDM, 24 which itself significantly compromises graft and patient survival. 25, 26 In order to assess bias in the model and determine if the mechanisms we generated are not simply artifacts of our particular causal model, we performed a series of negative con- b Possible is the number of expression changes downstream of the causal hypothesis for which the model can make predictions. Correct is for a given causal hypothesis the number of predicted changes that matched the observed direction of change, whether increased, decreased, or unchanged. Contradiction is for a given causal hypothesis the number of predicted changes that do not match the observed direction of change. Conflict is for a given causal hypothesis the number of expression changes ambiguously determined from the model.
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c Richness is for a given causal hypothesis the probability that the number of observed changes in a given model could have occurred by chance alone. Concordance is for a given causal hypothesis the probability that the number of observed changes that match the directionality of the changes predicted by the model could have occurred by chance alone. trol causal analyses. We generated randomized expression profiles with similar model connectivity as our experimentally derived profiles and performed reverse causal analysis on these randomized profiles. We observed negligible overlap between the hypotheses generated from random and experimental profiles. We also noted that the scores that we observed with our randomized profiles were much less significant than the scores from experimental profiles (data not shown).
CONCLUSIONS
In this paper, we describe a novel approach to define discrete, altered mechanisms of regulation in DM2. Our approach integrates genome-wide profiling measurements with system-level models of molecular cause-and-effect relationships and uses computer-aided causal analysis to define discrete mechanisms of regulation. Through causal analysis we showed evidence of discovery of those genes mechanistically linked to alteration in RNA profiles in diabetes, confirmed the coordinate downregulation of genes involved in OXPHOS transcription, and further predicted glucose transport and insulin signaling outcomes. We also showed the utility of this model for hypothesis generation and discovery of a previously unrecognized mechanisms of regulation in DM2, as evidenced by the finding of skeletal muscle calcineurin expression linked to insulin sensitivity and glucose tolerance in PTDM. The emerging hypotheses describe biologic effects in DM2 and offer important cues for molecular targeted therapy. These findings show the utility of causal reasoning models for hypotheses generation and suggest a powerful new approach for interpretation of transcript profiling in drug discovery. 
